--- title: "Immunotech Biopharm (6978) stock: news and investor profile" url: "https://aibio.space/companies/immunotech-biopharm/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Immunotech Biopharm Ltd (HKEX: 6978), China. The directory classifies it as Pharmaceuticals: Major." --- 6978 Immunotech Biopharm Ltd HKEX · China # Immunotech Biopharm (6978) news Immunotech Biopharm Ltd is a public biotech or pharmaceutical company listed on HKEX under the ticker 6978, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Immunotech Biopharm news We have not published a story on Immunotech Biopharm yet. When there is news, it will appear here. ## Immunotech Biopharm at a glance - **Ticker**: 6978 - **Listing**: HKEX - **Country**: China ### Related companies - [Transcenta Holding](https://aibio.space/companies/transcenta/) HKEX: 6628 - [Zhong Zhu Healthcare Holding Co.](https://aibio.space/companies/zhong-zhu-healthcare/) SSE: 600568 - [HUBEI JUMPCAN PHARMACEUTICAL CO., LTD](https://aibio.space/companies/hubei-jumpcan-pharmaceutical/) SSE: 600566 - [Hightide Therapeutics](https://aibio.space/companies/hightide-therapeutics/) HKEX: 2511 - [Yifan Pharmaceutical Co.](https://aibio.space/companies/yifan-pharmaceutical/) SZSE: 002019 - [Akeso](https://aibio.space/companies/akeso/) HKEX: 9926 - [Zhejiang Garden Biopharmaceutical Co.,Ltd.](https://aibio.space/companies/zhejiang-garden-biopharmaceutical/) SZSE: 300401 - [Shanghai OPM Biosciences Co.](https://aibio.space/companies/shanghai-opm-biosciences/) SSE: 688293 ### Also on HKEX - [Beijing Tong Ren Tang Chinese Medicine Co.](https://aibio.space/companies/beijing-tong-ren-tang-chinese-medicine/) 3613 - [Beijing Biostar Pharmaceuticals Co.](https://aibio.space/companies/beijing-biostar-pharmaceuticals/) 2563 - [Hangzhou Jiuyuan Genetic Biopharmaceutical Co.](https://aibio.space/companies/hangzhou-jiuyuan-genetic-biopharmaceutical/) 2566 - [Regent Pacific Group](https://aibio.space/companies/regent-pacific/) 575 - [China Resources Pharmaceutical Group](https://aibio.space/companies/china-resources-pharmaceutical/) 3320 - [Simcere Pharmaceutical Group](https://aibio.space/companies/simcere-pharmaceutical/) 2096 ## Questions about Immunotech Biopharm What is the ticker symbol of Immunotech Biopharm? Immunotech Biopharm Ltd trades under the ticker 6978 on HKEX. Where is Immunotech Biopharm listed? Immunotech Biopharm Ltd is listed on HKEX. Which country or territory is Immunotech Biopharm listed under? Our directory records Immunotech Biopharm Ltd under China. What does Immunotech Biopharm do? Our directory classifies Immunotech Biopharm Ltd as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Immunotech Biopharm? The ISIN recorded for Immunotech Biopharm Ltd is KYG4721A1004. Does aibio.space cover Immunotech Biopharm? aibio.space lists Immunotech Biopharm Ltd among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Immunotech Biopharm? Companies in our directory listed in the same country and business area as Immunotech Biopharm: Transcenta Holding, Zhong Zhu Healthcare Holding Co., HUBEI JUMPCAN PHARMACEUTICAL CO., LTD, Hightide Therapeutics, Yifan Pharmaceutical Co., Akeso. ## Investor discussion: Immunotech Biopharm Members talk about Immunotech Biopharm (6978). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Immunotech Biopharm, newest first. Each line links the filing it comes from. 1. 2026-04-29 Listings Trading status: EXCHANGE NOTICE - RESUMPTION OF TRADING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0429/2026042900283.htm) 2. 2026-04-28 Listings Trading status: (1) INSIDE INFORMATION UPDATE ON CONDITIONAL NEW DRUG APPLICATION FOR EAL FOR THE PREVENTION OF POSTOPERATIVE RECURRENCE OF LIVER CANCER (2) RESUMPTION OF TRADING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042804811.pdf) 3. 2026-04-28 Listings Trading status: TRADING HALT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042800451.pdf) 4. 2026-04-28 Listings Trading status: EXCHANGE NOTICE - TRADING HALT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042800429.htm) 5. 2026-02-25 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION SUBSCRIPTION OF STRUCTURED DEPOSIT PRODUCT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0225/2026022501180.pdf) 6. 2026-02-13 Financings Share or debt issue: COMPLETION OF ISSUE OF NEW CONVERTIBLE BONDS UNDER GENERAL MANDATE AND THE NOTE AND SETTLEMENT OF THE 2023 CONVERTIBLE BONDS. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0213/2026021301833.pdf) 7. 2026-02-09 Financings Share or debt issue: PROPOSED ISSUE OF NEW CONVERTIBLE BONDS UNDER GENERAL MANDATE AND THE NOTE AND SETTLEMENT OF THE 2023 CONVERTIBLE BONDS. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0209/2026020901520.pdf) 8. 2026-01-20 Financings Share or debt issue: FRAMEWORK AGREEMENT IN RELATION TO THE ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE AND THE NOTE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0120/2026012001365.pdf) 9. 2025-12-08 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION SUBSCRIPTION OF STRUCTURED DEPOSIT PRODUCTS. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1208/2025120801544.pdf) 10. 2025-11-12 Financings Share or debt issue: RESULTS OF RIGHTS ISSUE ON THE BASIS OF ONE (1) RIGHTS SHARE FOR EVERY FIVE (5) EXISTING SHARES HELD ON THE RECORD DATE AND ADJUSTMENTS TO THE CONVERSION PRICES OF THE CONVERTIBLE BONDS AND THE EXERCISE PRICE OF THE SHARE OPTIONS UNDER THE PRE-IPO SHARE OPTION SCHEME. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1112/2025111201424.pdf) 11. 2025-10-13 Financings Share or debt issue: EXCESS APPLICATION FORM. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1013/2025101301101.pdf) 12. 2025-10-13 Financings Share or debt issue: PROVISIONAL ALLOTMENT LETTER. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1013/2025101301099.pdf) 13. 2025-10-13 Financings Share or debt issue: RIGHTS ISSUE ON THE BASIS OF ONE (1) RIGHTS SHARE FOR EVERY FIVE (5) EXISTING SHARES HELD ON THE RECORD DATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1013/2025101301093.pdf) 14. 2025-09-22 Listings Trading status: EXCHANGE NOTICE - RESUMPTION OF TRADING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0922/2025092200117.htm) 15. 2025-09-19 Listings Trading status: (1) PROPOSED RIGHTS ISSUE ON THE BASIS OF ONE (1) RIGHTS SHARE FOR EVERY FIVE (5) EXISTING SHARES HELD ON THE RECORD DATE (2) RESUMPTION OF TRADING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0919/2025091901706.pdf) 16. 2025-09-19 Listings Trading status: TRADING HALT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0919/2025091900197.pdf) 17. 2025-09-19 Listings Trading status: EXCHANGE NOTICE - TRADING HALT. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0919/2025091900179.htm) ## Press releases Headlines of Immunotech Biopharm's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-09-30 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0930/2026093001805.pdf) 2. 2026-08-21 HKEXnews [ANNOUNCEMENT OF THE INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0821/2026082102157.pdf) 3. 2026-06-03 HKEXnews [VOLUNTARY ANNOUNCEMENT UPDATE ON STATUS OF EAL AND APPROVAL FOR CLINICAL TRANSLATIONAL APPLICATION OF ATL](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0603/2026060302944.pdf) 4. 2026-04-30 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 30 APRIL 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0430/2026043003530.pdf) 5. 2026-04-29 HKEXnews [EXCHANGE NOTICE - RESUMPTION OF TRADING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0429/2026042900283.htm) 6. 2026-04-28 HKEXnews [(1) INSIDE INFORMATION UPDATE ON CONDITIONAL NEW DRUG APPLICATION FOR EAL FOR THE PREVENTION OF POSTOPERATIVE RECURRENCE OF LIVER CANCER (2) RESUMPTION OF TRADING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042804811.pdf) 7. 2026-04-28 HKEXnews [TRADING HALT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042800451.pdf) 8. 2026-04-28 HKEXnews [EXCHANGE NOTICE - TRADING HALT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042800429.htm) 9. 2026-04-07 HKEXnews [CHANGE OF DATE OF ANNUAL GENERAL MEETING AND BOOK CLOSURE PERIOD](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0407/2026040700217.pdf) 10. 2026-04-07 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0407/2026040700213.pdf) 11. 2026-03-20 HKEXnews [TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0320/2026032002142.pdf) 12. 2026-03-20 HKEXnews [TERMS OF REFERENCE OF THE AUDIT COMMITTEE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0320/2026032002138.pdf) 13. 2026-03-20 HKEXnews [ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0320/2026032002136.pdf) 14. 2026-02-25 HKEXnews [DISCLOSEABLE TRANSACTION SUBSCRIPTION OF STRUCTURED DEPOSIT PRODUCT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0225/2026022501180.pdf) 15. 2026-02-13 HKEXnews [COMPLETION OF ISSUE OF NEW CONVERTIBLE BONDS UNDER GENERAL MANDATE AND THE NOTE AND SETTLEMENT OF THE 2023 CONVERTIBLE BONDS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0213/2026021301833.pdf) 16. 2026-02-09 HKEXnews [PROPOSED ISSUE OF NEW CONVERTIBLE BONDS UNDER GENERAL MANDATE AND THE NOTE AND SETTLEMENT OF THE 2023 CONVERTIBLE BONDS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0209/2026020901520.pdf) 17. 2026-01-27 HKEXnews [CONTINUING CONNECTED TRANSACTION IN RELATION TO PROVISION OF CELL THERAPY PROCESSING SERVICES TO TASLY](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0127/2026012701285.pdf) 18. 2026-01-20 HKEXnews [FRAMEWORK AGREEMENT IN RELATION TO THE ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE AND THE NOTE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0120/2026012001365.pdf) 19. 2025-12-08 HKEXnews [DISCLOSEABLE TRANSACTION SUBSCRIPTION OF STRUCTURED DEPOSIT PRODUCTS](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1208/2025120801544.pdf) 20. 2025-11-12 HKEXnews [RESULTS OF RIGHTS ISSUE ON THE BASIS OF ONE (1) RIGHTS SHARE FOR EVERY FIVE (5) EXISTING SHARES HELD ON THE RECORD DATE AND ADJUSTMENTS TO THE CONVERSION PRICES OF THE CONVERTIBLE BONDS AND THE EXERCISE PRICE OF THE SHARE OPTIONS UNDER THE PRE-IPO SHARE OPTION SCHEME](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1112/2025111201424.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:6978 on TradingView](https://www.tradingview.com/symbols/HKEX-6978/). ## Listing details Immunotech Biopharm Ltd is a public biotech or pharmaceutical company listed on HKEX under the ticker 6978, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Immunotech Biopharm Ltd - **Ticker**: 6978 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Pharmaceuticals: Major - **ISIN**: KYG4721A1004 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-6978/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/immunotech-biopharm/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Immunotech Biopharm (6978) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/immunotech-biopharm/